Name: niketa Order ID: 3083690

ITDOSE INFOSYSTEMS PVT. LTD.

Age/Gender: 33 Y/Female Registration Date: 19/Jun/2021 04:04PM

Patient ID: 012106190912 Collection Date: 19/Jun/2021 12:38PM
Barcode ID: A4003541 Sample Receive Date: 19/Jun/2021 06:10PM
Referred By: Self Report Status: Interim
SampleType: Plasma Report Date: 19/Jun/2021 07:33PM

HAEMATOLOGY
Test Name Result Unit Bio Ref.Interval Method

D-DIMER
D-Dimer 221.00 ng/mL 0 - 250 Chemiluminescent
immunometric assay
Test Interpretation and Clinical use:

The formation of D-Dimer requires three hemostatic stages: formation of clot (coagulation), Factor XIIIa crosslinking, and clot
breakdown of fibrin (fibrinolysis).
A correlation of increased D-dimer levels is associated with clinical conditions that relate to the formation of fibrin, mirroring an
in vivo lysis of formed cross-linked fibrin.
Timely, accurate, and fast D-dimer assay could provide significant utility for managing and monitoring patients with suspected
DVT and Disseminated intravascular coagulation (DIC)
Pulmonary embolism (PE)- Pulmonary embolism may result from deep vein thrombosis; hence, stressing an essential need of
early diagnosis and treatment of DVT.
Miscellaneous causes like Postoperative states, malignancy, trauma, and pre-eclampsia leads to elevated D-Dimer.
Patients with severe COVID-19 have a higher level of D-dimer than those with non-severe disease

Limitations of D Dimer Assay:

1. D dimer half-life is approximately 6 hours in circulation of individuals with normal renal function.
2. Patients with stabilized clots and not undergoing active fibrin deposition and plasmin activation may not give detectable D
dimer elevations.
3. In PE, the larger the clot size, higher the expected level of circulating D dimer. Conversely, the amount of D-dimer release
from very small clots may be diluted by the circulation and may not give a detectable increase.
4. Fibrinolysis is a highly regulated process and in delicate dynamic balance. In case of hereditary, acquired deficiency and
dysfunction of Fibrinogen, the rate of fibrinolysis will be altered there by not giving detectable D dimer levels.
5. False positives may be seen with high levels of rheumatoid factor, bilirubin, lipemic sera and hemolyzed blood.

Note :

For diagnostic purposes, the results obtained from this assay should always be used in combination with the clinical examination,
patient medical history, and other findings.

Kindly correlate clinically

Page 1 of 2
Name: niketa Order ID: 3083690
Age/Gender: 33 Y/Female Registration Date: 19/Jun/2021 04:04PM
Patient ID: 012106190912 Collection Date: 19/Jun/2021 12:38PM
Barcode ID: A4003541 Sample Receive Date: 19/Jun/2021 06:10PM
Referred By: Self Report Status: Interim
SampleType: Plasma Report Date: 19/Jun/2021 07:33PM

HAEMATOLOGY
Test Name Result Unit Bio Ref.Interval Method

*** End Of Report ***

Kindly correlate clinically

Page 2 of 2